Type 1 Diabetes News and Research

RSS
Type 1 diabetes, formerly called juvenile diabetes or insulin-dependent diabetes, is usually first diagnosed in children, teenagers, or young adults. In this form of diabetes, the beta cells of the pancreas no longer make insulin because the body’s immune system has attacked and destroyed them. Treatment for type 1 diabetes includes taking insulin shots or using an insulin pump, making wise food choices, exercising regularly, controlling blood pressure and cholesterol, and taking aspirin daily—for some.
Preventing Immunological Rejection Following Transplantation

Preventing Immunological Rejection Following Transplantation

Study Delves Deeper into Understanding How Humans Behave

Study Delves Deeper into Understanding How Humans Behave

Study Solves Mystery and Establish the Mechanism Underlying SLC29A3 Disorders

Study Solves Mystery and Establish the Mechanism Underlying SLC29A3 Disorders

T-Cell Analysis for Type 1 Diabetes Preventive Therapy

T-Cell Analysis for Type 1 Diabetes Preventive Therapy

Glucose-Sensing Neurons May Play a Role in Regulating Blood Sugar

Glucose-Sensing Neurons May Play a Role in Regulating Blood Sugar

Determining Disease Progression in Patients with Recent-Onset Type 1 Diabetes

Determining Disease Progression in Patients with Recent-Onset Type 1 Diabetes

Study Tracks How the Gut Microbiota Changes During First Three Months of Life

Study Tracks How the Gut Microbiota Changes During First Three Months of Life

Two subtypes of cells that produce insulin discovered

Two subtypes of cells that produce insulin discovered

Artificial pancreas helps improve blood sugar control in children with type 1 diabetes

Artificial pancreas helps improve blood sugar control in children with type 1 diabetes

Study: Oral verapamil improves the pancreas' insulin secretion in children with newly-diagnosed TID

Study: Oral verapamil improves the pancreas' insulin secretion in children with newly-diagnosed TID

Massive clinical study on type 1 diabetes patients

Massive clinical study on type 1 diabetes patients

Georgia Tech researchers develop a new biomaterial that could cure Type 1 diabetes

Georgia Tech researchers develop a new biomaterial that could cure Type 1 diabetes

Bacterial warfare in the gut can have collateral beneficial effects

Bacterial warfare in the gut can have collateral beneficial effects

COVID-19 vaccination stimulates antibodies aiming parts of virus spike protein among corona variants, researchers discover

COVID-19 vaccination stimulates antibodies aiming parts of virus spike protein among corona variants, researchers discover

Giving attention to beta cells instead of the immune system could be a chance to prevent type 1 diabetes

Giving attention to beta cells instead of the immune system could be a chance to prevent type 1 diabetes

Researchers demonstrate a possible new way of generating insulin-producing cells

Researchers demonstrate a possible new way of generating insulin-producing cells

Characterizing the genetic factors impacting the immune response in type 1 diabetes

Characterizing the genetic factors impacting the immune response in type 1 diabetes

Researchers create RNA molecules to address human pancreatic beta cells

Researchers create RNA molecules to address human pancreatic beta cells

Novel ways to increase SC-beta cell’s survivability and functioning via genetic manipulation

Novel ways to increase SC-beta cell’s survivability and functioning via genetic manipulation

Researchers discover how pancreatic cells remodel themselves to reduce the immune response in patients at risk for T1D

Researchers discover how pancreatic cells remodel themselves to reduce the immune response in patients at risk for T1D

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.